Session » (1248–1271) Patient Outcomes, Preferences, & Attitudes Poster II

Date: Monday, October 27, 2025

Time: 10:30AM-12:30PM

Meeting: ACR Convergence 2025

10:30AM-12:30PM: Abstract Number: 1249

Association between Positive Emotions and Physical Function in Early Rheumatoid Arthritis Patients

10:30AM-12:30PM: Abstract Number: 1264

Breaking the Veil: Preliminary Findings for a Qualitative Analysis of Rheumatoid Arthritis Patient Perspectives on Physical Activity and Mental Healt

10:30AM-12:30PM: Abstract Number: 1252

Can LLMs Categorize Patient Priorities Like Humans? Comparing AI and Human Coders in Arthritis Nominal Group Discussions

10:30AM-12:30PM: Abstract Number: 1268

Development of the LupusCoach Chatbot: Results of a Focus Group

10:30AM-12:30PM: Abstract Number: 1269

Dress for success: Influence of Rheumatologist Demographics and Attire on Patients with Chronic Inflammatory Arthritis Perceptions

10:30AM-12:30PM: Abstract Number: 1263

Health Literacy diversity among rheumatology patients: insights from a tertiary rheumatology centre

10:30AM-12:30PM: Abstract Number: 1270

Increasing Participation in the FT819 Cell Therapy Trial Amongst People Living with Lupus: A Focus Group Study

10:30AM-12:30PM: Abstract Number: 1260

Increasing Zoster Vaccination Rates in Immunosuppressed Veterans at the North Texas VA Medical Center Rheumatology Clinic

10:30AM-12:30PM: Abstract Number: 1257

Integrated Behavioral Health Services for Patients with Rheumatic Diseases: Qualitative Analysis of a Pilot Study

10:30AM-12:30PM: Abstract Number: 1255

Lung Transplantation Outcomes for Pulmonary Sarcoidosis Compared to Idiopathic Pulmonary Fibrosis: A Single Institution Multisite Experience

10:30AM-12:30PM: Abstract Number: 1271

Overcoming Obstacles to Care: Survey of Adult Patients with Idiopathic Inflammatory Myopathies (IIM)

10:30AM-12:30PM: Abstract Number: 1259

Patient and Caregiver Perspectives on the Burden of Disease in Uncontrolled Gout: A Cross-Sectional Survey Study

10:30AM-12:30PM: Abstract Number: 1248

Patient and Clinician Perception and Use of Complementary and Alternative (CAM) Medicine for Rheumatic Disease

10:30AM-12:30PM: Abstract Number: 1250

Patient Perceptions of the National Tele-Rheumatology Program: A Mixed Methods Study

10:30AM-12:30PM: Abstract Number: 1265

Patient Portal Awareness and Utilization Across Diverse Rheumatology Populations

10:30AM-12:30PM: Abstract Number: 1253

Patient Reported Outcome Measures: Assessing Resident Physician Acceptance of the Routine Assessment of Patient Index Data 3 Survey and its Impact on Physician-Patient Relationship

10:30AM-12:30PM: Abstract Number: 1267

Patient Reported Outcomes Predict Subsequent Treatment Intensification Among Rheumatoid Arthritis Patients: Longitudinal PRO Measurement Using a Mobile Health App

10:30AM-12:30PM: Abstract Number: 1262

Perspectives of Lupus Patients on Quality of Life Measures: A Qualitative Study

10:30AM-12:30PM: Abstract Number: 1256

Quantitative Analysis of a Pilot Study: Integrating Behavioral Health Services for Patients with Rheumatic Diseases

10:30AM-12:30PM: Abstract Number: 1266

Shared Decision Making in Rheumatoid Arthritis: Is RA disease activity associated with patient reported measures of shared decision making pre-SDM intervention?

10:30AM-12:30PM: Abstract Number: 1251

Steroids and Me (Sam): engaging and educating steroid-treated patients via patient advocacy partnerships and internet search channels.

10:30AM-12:30PM: Abstract Number: 1254

Symptom Burden and Treatment Experience in Fibromyalgia: Results From a National Patient Survey

10:30AM-12:30PM: Abstract Number: 1261

Use of telemedicine to address ‘off target’ symptoms in psoriatic arthritis (PsA): implementation of PsOWell™ in PsA

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].